STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Legence Reports Third Quarter 2025 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Legence (Nasdaq: LGN) reported record quarterly revenues of $708.0 million for Q3 2025, up 26.2% year-over-year, and non-GAAP Adjusted EBITDA of $88.8 million, up 38.9% year-over-year. Total backlog and awarded contracts reached $3.07 billion, a 29.4% increase, with a consolidated book-to-bill of 1.5x. The company used IPO net proceeds of $780.2 million to pay down term debt, reducing net debt to approximately $650 million and net leverage to 2.4x. Legence completed two tuck-in acquisitions (AZPE and IMD) and signed a definitive agreement to acquire Bowers for $475 million. Q4 2025 revenue guidance is $600M–$630M; full-year 2026 guidance is $2.65B–$2.85B revenue and $295M–$315M Adjusted EBITDA.

Legence (Nasdaq: LGN) ha riportato ricavi trimestrali record per 708,0 milioni di dollari nel Q3 2025, in aumento del 26,2% rispetto all'anno precedente, e un EBITDA rettificato non-GAAP di 88,8 milioni di dollari, in crescita del 38,9% annuo. L'arretrato totale e i contratti assegnati hanno raggiunto 3,07 miliardi di dollari, in aumento del 29,4%, con un rapporto book-to-bill consolidato di 1,5x. L'azienda ha utilizzato i proventi netti dell'offerta pubblica iniziale per estinguere debiti a termine, riducendo il debito netto a circa 650 milioni di dollari e la leva netta a 2,4x. Legence ha completato due acquisizioni "tuck-in" (AZPE e IMD) e ha firmato un accordo definitivo per acquisire Bowers per 475 milioni di dollari. Le guidance per Q4 2025 sulle entrate è 600–630 milioni di dollari; la guidance per l'intero 2026 è 2,65–2,85 miliardi di dollari di entrate e 295–315 milioni di dollari di EBITDA rettificato.

Legence (Nasdaq: LGN) informó ingresos trimestrales récord en el Q3 2025 de $708.0 millones, un crecimiento interanual del 26.2%, y un EBITDA ajustado no GAAP de $88.8 millones, un incremento interanual del 38.9%. El backlog total y contratos otorgados alcanzaron $3.07 mil millones, un aumento del 29.4%, con un book-to-bill consolidado de 1.5x. La compañía utilizó los ingresos netos de la OPI de $780.2 millones para reducir la deuda a término, reduciendo la deuda neta a aproximadamente $650 millones y la palanca neta a 2.4x. Legence completó dos adquisiciones de tuck-in (AZPE y IMD) y firmó un acuerdo definitivo para adquirir Bowers por $475 millones. La guía de ingresos para el Q4 2025 es $600M–$630M; la guía para todo 2026 es $2.65B–$2.85B de ingresos y $295M–$315M de EBITDA ajustado.

Legence (나스닥: LGN)은 2025년 3분기에 기록적인 분기 매출 7.08억 달러, 전년 대비 26.2% 증가, 비-GAAP 조정된 EBITDA 8,880만 달러, 전년 대비 38.9% 증가를 보고했습니다. 총 백로그와 수주 계약은 30.7억 달러에 도달했고, 이는 29.4% 증가했으며, 통합적 주문-매출 비율은 1.5x입니다. 이 회사는 IPO 순수익 7.802억 달러를 사용해 기간부 부채를 상환하여 순부채를 약 6.50억 달러로, 순레버리지를 2.4x로 감소시켰습니다. Legence는 두 차례의 tuck-in 인수(AZPE와 IMD)를 완료했고, Bowers를 4.75억 달러에 인수하는 확정 계약을 체결했습니다. 2025년 4분기 매출 가이드는 6억–6.3억 달러, 2026년 연간 매출 가이드는 26.5–28.5억 달러, 그리고 2.95–3.15억 달러의 조정 EBITDA입니다.

Legence (Nasdaq : LGN) a enregistré des revenus trimestriels records pour le T3 2025 de 708,0 millions de dollars, en hausse de 26,2 % sur un an, et un EBITDA ajusté non-GAAP de 88,8 millions de dollars, en hausse de 38,9 % sur un an. Le backlog total et les contrats attribués atteignaient 3,07 milliards de dollars, en hausse de 29,4 %, avec un book-to-bill consolidé de 1,5x. L'entreprise a utilisé les produits nets de l'IPO de 780,2 millions de dollars pour rembourser une dette à terme, réduisant la dette nette à environ 650 millions de dollars et l'effet de levier net à 2,4x. Legence a réalisé deux acquisitions tuck‑in (AZPE et IMD) et a signé un accord définitif pour acquérir Bowers pour 475 millions de dollars. Les prévisions de revenus pour Q4 2025 s'élèvent à 600–630 millions de dollars; les prévisions pour l'ensemble de 2026 s'établissent à 2,65–2,85 milliards de dollars de revenus et 295–315 millions de dollars d'EBITDA ajusté.

Legence (Nasdaq: LGN) meldete im dritten Quartal 2025 Rekordumsätze von 708,0 Mio. USD, eine Steigerung von 26,2% gegenüber dem Vorjahr, und ein non-GAAP Adjusted EBITDA von 88,8 Mio. USD, ein Anstieg von 38,9% gegenüber dem Vorjahr. Der gesamte Backlog und beauftragte Verträge erreichten 3,07 Mrd. USD, eine Steigerung um 29,4%, mit einem konsolidierten Book-to-Bill von 1,5x. Das Unternehmen setzte die Nettoerlöse aus dem IPO in Höhe von 780,2 Mio. USD ein, um Term Debt zu tilgen, wodurch die Nettoverschuldung auf etwa 650 Mio. USD und die Nettoschuld-Leverage auf 2,4x sinke. Legence schloss zwei tuck-in Akquisitionen (AZPE und IMD) ab und unterzeichnete eine endgültige Vereinbarung zum Erwerb von Bowers für 475 Mio. USD. Die Umsatzprognose für Q4 2025 liegt bei 600–630 Mio. USD; die Full-Year-Prognose 2026 liegt bei 2,65–2,85 Mrd. USD Umsatz und 295–315 Mio. USD Adjusted EBITDA.

ليجينس (ناسداك: LGN) أبلغت عن إيرادات ربع سنوية قياسية للربع الثالث 2025 قدرها 708.0 مليون دولار، بارتفاع 26.2% على أساس سنوي، وEBITDA معدّل غير GAAP بقيمة 88.8 مليون دولار، بارتفاع 38.9% على أساس سنوي. وصل الإجمالِي المتراكم والعقود الممنوحة إلى 3.07 مليار دولار، بزيادة قدرها 29.4%، مع نسبة الكتاب إلى الطلب المجمّع قدرها 1.5x. استخدمت الشركة عائدات الطرح العام الأولي الصافية البالغة 780.2 مليون دولار لسداد الدين القرضي، مما خفّض الدين الصافي إلى نحو 650 مليون دولار والرفع المالي الصافي إلى 2.4x. أكملت ليجينس عمليتي استحواذ tuck-in (AZPE وIMD) ووقعت اتفاقاً نهائياً للاستحواذ على Bowers بمقدار 475 مليون دولار. التوجيه لإيرادات الربع الرابع 2025 هو 600–630 مليون دولار؛ والتوجيه للسنة الكاملة 2026 هو 2.65–2.85 مليار دولار من الإيرادات و 295–315 مليون دولار من EBITDA المعدل.

Positive
  • Revenue +26.2% YoY to $708.0M in Q3 2025
  • Adjusted EBITDA +38.9% YoY to $88.8M
  • Backlog $3.07B, up 29.4% YoY; book-to-bill 1.5x
  • IPO proceeds $780.2M used to reduce term loan; net debt ~$650M
  • Signed acquisition of Bowers for $475M to expand Mid-Atlantic footprint
  • Tuck-in acquisitions (AZPE and IMD) adding ~$25M combined 2025 revenues
Negative
  • Consolidated gross margin down to 20.9% from 21.1% year-over-year
  • GAAP net loss of $0.6M in Q3 2025 (loss per share $(0.02))
  • Guidance excludes the Bowers acquisition, leaving 2026 impact uncertain

Insights

Strong organic growth, margin expansion, leverage reduction, and an accretive M&A pipeline position the company favorably near-term.

Legence delivered record quarterly revenue of $708.0 million, a year-over-year increase of 26.2%, and non-GAAP Adjusted EBITDA of $88.8 million, up 38.9%. Consolidated gross margin held near prior levels at 20.9%, while Installation & Maintenance drove most revenue growth and margin gains.

The balance sheet shows material deleveraging following the IPO with net proceeds of $780.2 million applied to debt, reducing net debt to $650 million and net leverage to 2.4x. The company also announced a $475 million definitive agreement to acquire Bowers, expected to close in Q1 2026, and completed two smaller tuck-in acquisitions with combined 2025 revenues of ~$25 million.

Key dependencies and near-term items to watch include execution against guidance for Q4 2025 (revenues $600M–$630M, Adjusted EBITDA $60M–$65M), full year 2026 guidance, the closing and terms of the Bowers acquisition, and realization of projected cross-selling from recent tuck-ins. These items will determine whether current growth and deleveraging trends sustain into the next fiscal year.

Record Quarterly Revenues of $708.0 Million, a 26% Increase from a Year Ago
 
Quarterly Adjusted EBITDA (non-GAAP) Increased 39% from Prior Year
 
Record Total Backlog and Awards of $3.1 Billion, 29% Increase from a Year Ago, with Robust Book-to-Bill of 1.5x
 
Signed Definitive Agreement to Acquire Bowers, a Premier Mechanical Contractor in the Northern Virginia/DC Metro
Area for Total Consideration of $475 Million
 
Tuck-In Acquisitions of Engineering Firm and Mechanical Contractor Provide Cross Selling Opportunities and
Access to Strategic End Markets
 
Total Debt and Net Debt (non-GAAP) Declines to $836 Million and $650 Million, respectively, on IPO Proceeds
and Strong Cash Generation1
 
Establish Fourth Quarter 2025 Guidance for Revenue of $600 Million - $630 Million and Non-GAAP Adjusted
EBITDA of $60 Million - $65 Million
 
Establish Full Year 2026 Guidance for Revenue of $2.65 Billion - $2.85 Billion and Non-GAAP Adjusted EBITDA
of $295 Million - $315 Million
 

SAN JOSE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today reported financial results for the third quarter ended September 30, 2025.

Jeff Sprau, Chief Executive Officer of Legence, commented, “I am extremely proud of our entire Legence team for the successful initial public offering, and extend my sincere gratitude to the many investors who have placed their trust and confidence with us. In our inaugural quarterly report as a public company, we are pleased to deliver exceptional results, highlighted by robust organic revenue, Adjusted EBITDA and backlog growth, fueled by strong demand for our services across key end markets. We are also delivering on our strategic commitment to reduce leverage, through a combination of debt paydown with proceeds from the IPO and operational execution that resulted in healthy cash generation. We remain optimistic about our future, as the comprehensive capabilities of our Legence team coupled with the market trends that have propelled our success to date, provide a firm basis for our positive outlook.”

Third Quarter 2025 Consolidated Results:

Revenues for the third quarter of 2025 totaled $708.0 million, an increase of 26.2% from $560.8 million for the third quarter of 2024. Gross profit for the third quarter of 2025 was $148.1 million with gross margin of 20.9%, compared to gross profit of $118.5 million and gross margin of 21.1% for the third quarter of 2024. Net loss attributable to Legence for the third quarter of 2025 was $(0.6) million, or $(0.02) per diluted share, compared to a net loss of $1.1 million for the third quarter of 2024. Non-GAAP Adjusted EBITDA for the third quarter of 2025 was $88.8 million, an increase of 38.9% from $64.0 million for the third quarter of 2024. Refer to “Non-GAAP Financial Measures” for a reconciliation of Adjusted EBITDA to the most directly comparable GAAP measure.

Legence Corp. Consolidated Results
($ in thousands)

 Three Months Ended September 30,       
 2025
 2024
 Year over Year Change 
 $ % $ % $ % 
Revenues:                  
Engineering & Consulting$212,172 30.0% $193,797 34.6% $18,375 9.5% 
Installation & Maintenance 495,834 70.0%  367,007 65.4%  128,827 35.1% 
Consolidated Revenues$708,006 100.0% $560,804 100.0% $147,202 26.2% 
                   
                   
 Three Months Ended September 30,       
 2025
 2024
 Year over Year Change 
 $ % Margin $ % Margin $ % 
Gross Profit:                  
Engineering & Consulting$67,326 31.7% $63,945 33.0% $3,381 5.3% 
Installation & Maintenance 80,733 16.3%  54,601 14.9% $26,132 47.9% 
Consolidated Gross Profit$148,059 20.9% $118,546 21.1% $29,513 24.9% 
                   
Non-GAAP Adjusted EBITDA$88,821 12.5% $63,956 11.4% $24,865 38.9% 
 

Engineering & Consulting Segment Results:

Engineering & Consulting segment revenue for the third quarter of 2025 totaled $212.2 million, an increase of 9.5% from $193.8 million for the third quarter of 2024, driven by higher demand for Engineering & Design service line, primarily from state & local government and life sciences & healthcare clients, and higher demand for Program & Project Management service line, primarily from hospitality & entertainment, partially offset by lower revenue from state & local government, education, and mixed-use clients.

Engineering & Consulting segment gross profit for the third quarter of 2025 totaled $67.3 million, an increase of 5.3% from $63.9 million for the third quarter of 2024. The increase was driven by organic revenue growth, partially offset by a slightly lower gross margin. The modest decrease in gross margin was driven by a higher percentage of subcontractor expenses and lower margin for the Engineering & Design service line, primarily from life sciences & healthcare and education clients, partially offset by a modest revenue mix shift towards the Engineering & Design service line.

Engineering & Consulting Segment Results
($ in thousands)

 Three Months Ended September 30,       
 2025
 2024
 Year over Year Change 
 $ % $ % $ % 
Segment Revenues:                  
Engineering & Design$110,939 52.3% $99,712 51.5% $11,227 11.3% 
Program & Project Management 101,233 47.7%  94,085 48.5%  7,148 7.6% 
Engineering & Consulting Revenues$212,172 100.0% $193,797 100.0% $18,375 9.5% 
                   
                   
 Three Months Ended September 30,       
 2025
 2024
 Year over Year Change 
 $ % Margin $ % Margin $ % 
Engineering & Consulting Gross Profit$67,326 31.7% $63,945 33.0% $3,381 5.3% 
 

Installation & Maintenance Segment Results:

Installation & Maintenance segment revenue for the third quarter of 2025 totaled $495.8 million, an increase of 35.1% from $367.0 million for the third quarter of 2024. The increase was primarily due to greater demand in the Installation & Fabrication service line, primarily from data centers & technology as well as life sciences & healthcare clients, partially offset by lower revenue from mixed-use clients and hospitality & entertainment clients. Additionally, the revenue increase in our Maintenance & Service business was primarily due to strong demand from data centers & technology as well as life sciences & healthcare clients.

Installation & Maintenance segment gross profit for the third quarter of 2025 totaled $80.7 million, an increase of 47.9% from $54.6 million for the third quarter of 2024. The increase was primarily driven by strong revenue growth in both the Installation & Fabrication and Maintenance & Service service lines, as well as higher margins in the Installation & Fabrication service line, driven by strong project execution, partially offset by a revenue mix shift towards the Installation & Fabrication service line.

Installation & Maintenance Segment Results
($ in thousands)

 Three Months Ended September 30,   
 2025
 2024
 Year over Year Change 
 $ % $ % $ % 
Segment Revenues:                
Installation & Fabrication$408,717 82.4% $289,428 78.9% $119,289 41.2% 
Maintenance & Service 87,117 17.6%  77,579 21.1%  9,538 12.3% 
Installation & Maintenance Revenues$495,834 100.0% $367,007 100.0% $128,827 35.1% 
                   
                   
 Three Months Ended September 30,       
 2025
 2024
 Year over Year Change 
 $ % Margin $ % Margin $ % 
Installation & Maintenance Gross Profit$80,733 16.3% $54,601 14.9% $26,132 47.9% 
 

Backlog and Awarded Contracts2

Backlog and awarded contracts totaled $3.1 billion at September 30, 2025, an increase of 29.4% from $2.4 billion at September 30, 2024. The consolidated book-to-bill ratio was 1.5x for the three month period ended September 30, 2025. Engineering & Consulting segment backlog and awarded contracts increased by 1.5% year over year, as growth in the state & local government end market was largely offset by education, data centers & technology and mixed-use end markets. Installation & Maintenance segment backlog and awarded contracts increased by 45.9% year over year, primarily driven by new projects within the data center & technology and life science & healthcare end markets, partially offset by the education end market.

Backlog and Awarded Contracts
($ in thousands)

 As of September 30,
 Year over Year Change 
 2025
 2024
 $ % 
Engineering & Consulting$894,734  $881,469  $13,265 1.5% 
Installation & Maintenance 2,170,714   1,488,102   682,612 45.9% 
Total Backlog and Awarded Contracts$3,065,448  $2,369,571  $695,877 29.4% 
               
Book-to-bill ratio for the three months ended
    September 30
 1.5x  1.3x       
               
Book-to-bill ratio for the nine months ended
    September 30
 1.3x  1.4x       
               

Acquisitions

On October 1, 2025, Legence completed the acquisitions of Arizona Pinnacle Engineering, LLC. (“AZPE”) and Innovative Mechanical & Design, LLC (“IMD”). AZPE, founded in 2000, is a Phoenix, Arizona-based MEP engineering firm providing expertise to the data center and industrial markets, along with other mission critical end markets. IMD, founded in 2016, is a Colorado-based mechanical contractor primarily serving the healthcare, industrial and education end markets in the Mountain West region. Combined revenues from AZPE and IMD for the full calendar year 2025, including the period prior to the acquisition by the Company, are estimated to be approximately $25 million. Total consideration for IMD and AZPE was approximately $22 million, of which approximately 21% was paid in equity.

Jeff Sprau, Chief Executive Officer of Legence, commented, “Legence is thrilled to welcome both Arizona Pinnacle Engineering and Innovative Mechanical & Design to our growing platform. AZPE has established itself as a well-respected, specialized engineering firm in the Phoenix, Arizona area that has successfully partnered with our Installation & Maintenance business on past projects. IMD expands our capabilities in the attractive Colorado and surrounding region marketplace, adds to our healthcare and education client base, and offers an additional area to expand our fabrication capacity. Both companies are examples of our thoughtful M&A strategy, offering strategic and cultural fit, strong returns and clear cross-selling opportunities.”

Additionally, the Company today announced that it has entered into a definitive agreement to acquire The Bowers Group, Inc. (“Bowers”), a premier mechanical contractor headquartered in Beltsville, Maryland. Bowers specializes in providing comprehensive mechanical and plumbing solutions for complex building systems, serving a broad customer base primarily in the Northern Virginia and DC Metro region. Information about the transaction can be found on the Company’s investor relations website: https://investors.wearelegence.com/.

Balance Sheet

Upon successful completion of the Company’s initial public offering (“IPO”), including the partial exercise of the over-allotment option, Legence applied net proceeds of $780.2 million, after deducting underwriting discounts and commissions, to pay down a portion of our outstanding term loan facility. As a result, net debt as of September 30, 2025 was approximately $650 million and net leverage was 2.4 times, based on non-GAAP Adjusted EBITDA for the last 12 months ended September 30, 2025. See “Non-GAAP Financial Measures” for information regarding net debt and net leverage. As previously disclosed, on October 30, 2025, we entered into an amendment to our existing credit agreement, extending the maturity date of the term loan facility by three years to December 16, 2031 and reducing the applicable interest rate to Secured Overnight Financing Rate (SOFR) by 25 basis points. We also amended our revolving credit facility to increase the aggregate commitment amount to $200.0 million, extend the maturity date by approximately four years to September 22, 2030, and conform the interest rate applicable to the revolving credit facility to that of the term loan credit facility.

Guidance

Legence announces the following guidance for the fourth quarter of 2025:

  • Total revenues of $600 million to $630 million; and
  • Non-GAAP adjusted EBITDA of $60 million to $65 million.

Legence announces the following guidance for full year 2026:

  • Total revenues of $2.65 billion to $2.85 billion; and
  • Non-GAAP Adjusted EBITDA of $295 million to $315 million.

The guidance provided reflects Legence’s current operations and excludes any effect from the announced acquisition of Bowers, which is expected to close in the first quarter of 2026, pending customary closing conditions and regulatory approval. Information about the transaction, including separate guidance for Bowers, can be found on the Company’s investor relations website: https://investors.wearelegence.com/.

Conference Call

Legence will host a webcast and conference call to discuss its financial results on November 14, 2025 at 10:00 a.m. (Eastern Time). The webcast link to the call and the slide presentation to accompany the call remarks can be accessed on the Company’s website at https://investors.wearelegence.com/. A replay of the webcast can be accessed through the same webcast link on the Company’s website shortly after the call and will be available through December 14, 2025.

About Legence

Legence is a leading provider of engineering, consulting, installation, and maintenance services for mission-critical systems in buildings. The Company specializes in designing, fabricating, and installing complex HVAC, process piping, and other mechanical, electrical and plumbing (MEP) systems—enhancing energy efficiency, reliability, and sustainability in new and existing facilities. Legence also delivers long-term performance through strategic upgrades and holistic solutions. Serving some of the world’s most technically demanding sectors, Legence counts over 60% of the Nasdaq-100 Index among its clients.

Forward Looking Statements

Certain statements contained in this press release constitute “forward-looking statements.” All statements, other than statements of historical fact included in this press release regarding our strategy, future operations, financial position and guidance, estimated revenues and losses, projected costs, prospects, plans and objectives of management, are forward-looking statements. When used in this press release, words such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements are not historical facts but rather are based on management’s current belief, based on currently available information, as to the outcome and timing of future events, and it is possible that the results described in this press release will not be achieved. Such statements are subject to risks, uncertainties and other factors, many of which are outside of the Company’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, changes to economic and regulatory conditions and other trends in the markets in which we operate; our ability to compete effectively in our target markets; the business plans or financial condition of our customers; the regulations related to environmental, health and safety matters; the ability to receive necessary government permits and approvals; the future availability and price of materials and equipment necessary for the performance of our business; the risks associated with inflation, interest rates, recessionary economic conditions and commodity prices; the fact that we outsource various elements of the services we sell and use materials and equipment produced by third parties; our clients’ reliance on third party financing; the recognition of all revenues from our backlog and awarded contracts; our receipt of all payments anticipated under awarded projects and customer contracts; the maintenance of safe work sites and equipment; restrictions imposed by our existing and any future indebtedness; our exposure to costs and liabilities under environmental, health and safety laws; misconduct and errors by employees, subcontractors, partners or third party service providers; and the other risks described under the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our final prospectus, dated September 11, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to Rule 424(b)(4) of the Securities Act of 1933, as amended, on September 15, 2025 (the “Prospectus”), in connection with our IPO. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for the Company to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in the Prospectus and in the Company’s subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements.

Contact

Media: media@wearelegence.com
Investor Relations: ir@wearelegence.com

Legence Corp.
Condensed Consolidated Statements of Operations
(In thousands, except per share data) (Unaudited)
 
 Three Months Ended
September 30,
 Nine Months Ended
September 30,
 
 2025
 2024
 2025
 2024
 
Revenue$708,006  $560,804  $1,812,849  $1,550,387  
Cost of revenue 559,947   442,258   1,424,412   1,232,561  
        Gross profit 148,059   118,546   388,437   317,826  
                 
Selling, general and administrative 85,887   67,199   227,814   179,848  
Depreciation and amortization 24,183   25,475   75,619   70,738  
Acquisition-related costs 795   154   971   5,593  
Loss (gain) on sale of property and equipment 21      (199)    
Equity in earnings of joint venture (24)  (1,233)  (848)  (3,131) 
        Income from operations 37,197   26,951   85,080   64,778  
                 
Other expense (income):                
Interest expense (including $3,312 and $3,368 for the
three months in 2025 and 2024, respectively, and
$11,776 and $9,963 for the nine months in 2025 and
2024, respectively, from related parties)
 28,183   23,707   88,228   65,392  
Interest income (1,069)  (523)  (2,588)  (4,356) 
Loss on debt extinguishment 5,685      5,685     
Credit agreement amendment fees 64      2,990   4,119  
Other income, net (123)  (121)  (268)  (434) 
        Total other expense, net 32,740   23,063   94,047   64,721  
        Income (loss) before income tax 4,457   3,888   (8,967)  57  
                 
Income tax expense 4,078   4,564   13,662   9,500  
        Net income (loss) 379   (676)  (22,629)  (9,443) 
Net income attributable to noncontrolling interests 955   407   4,430   407  
        Net loss attributable to Legence$(576) $(1,083) $(27,059) $(9,850) 
                 
 Period from
September 12,
2025 to
September 30,
2025
     Period from
September 12,
2025 to
September 30,
2025
     
Net loss per Class A Common Stock—
basic and diluted
$(0.02)     $(0.02)     
Weighted-average Class A Common Stock
outstanding—basic and diluted
 58,511       58,511      
 


Legence Corp.
Condensed Consolidated Balance Sheets
(In thousands) (Unaudited)
 
 September 30, 2025 December 31, 2024 
Assets        
Current assets:        
Cash and cash equivalents$176,034  $81,167  
Accounts receivable, net 588,433   448,610  
Contract assets, net 234,302   188,132  
Prepaid expenses and other current assets 39,038   38,506  
       Total current assets 1,037,807   756,415  
Property and equipment, net of accumulated depreciation of $92,084 and
$70,676 as of September 30, 2025 and December 31, 2024, respectively
 81,094   73,381  
Operating lease right-of-use assets (including $20,705 and $23,375 as of
September 30, 2025 and December 31, 2024, respectively,
from related parties)
 106,469   90,922  
Goodwill 782,931   781,194  
Intangible assets, net 562,361   624,250  
Other assets 29,607   26,338  
       Total assets$2,600,269  $2,352,500  
Liabilities and Equity        
Current liabilities:        
Accounts payable$224,256  $126,502  
Accrued compensation and benefits 89,832   54,601  
Accrued and other current liabilities 25,659   28,490  
Contract liabilities 285,894   164,130  
Current portion of operating lease liabilities (including $3,906 and $3,654
as of September 30, 2025 and December 31, 2024, respectively,
from related parties)
 18,051   14,402  
Current portion of long-term debt 16,301   22,984  
       Total current liabilities 659,993   411,109  
Long-term debt, net of current portion (including $87,486 and $211,039
as of September 30, 2025 and December 31, 2024, respectively,
from related parties)
 812,628   1,585,846  
Operating lease liabilities, net of current portion (including $17,997 and
$20,960 as of September 30, 2025 and December 31, 2024, respectively,
from related parties)
 94,568   80,669  
Tax receivable agreement liability - related party 146,474     
Deferred tax liabilities, net 41,543   35,428  
Other long-term liabilities 17,590   35,856  
       Total liabilities 1,772,796   2,148,908  
Commitments and contingencies         
Stockholders' equity / Member's equity        
Member's equity    443,738  
Preferred stock, $0.01 par value, 50,000,000 shares authorized, no shares
issued or outstanding as of September 30, 2025
      
Class A common stock $0.01 par value, 1,000,000,000 shares authorized,
58,510,567 shares issued and outstanding as of September 30, 2025
 585     
Class B common stock $0.01 par value, 200,000,000 shares authorized,
46,680,762 shares issued and outstanding as of September 30, 2025
 467     
Additional paid-in capital 664,299     
Accumulated deficit (277,228)  (250,169) 
Accumulated other comprehensive (loss) income (248)  9,111  
       Total Legence stockholders' equity / Member's equity 387,875   202,680  
Noncontrolling interests 439,598   912  
       Total stockholders' equity / Member's equity 827,473   203,592  
       Total liabilities and stockholders' equity / Member's equity$2,600,269  $2,352,500  
 


Legence Corp.
Condensed Consolidated Statements of Cash Flows
(In thousands) (Unaudited)
 
 Nine Months Ended September 30, 
 2025
 2024
 
Cash flows from operating activities:        
Net loss$(22,629) $(9,443) 
Adjustments to reconcile net loss to cash provided by operating activities:        
Amortization of intangible assets 61,888   59,506  
Depreciation of property and equipment 23,723   21,481  
Amortization of debt issuance costs and discounts 3,007   3,665  
Stock-based compensation 21,881   8,726  
Deferred taxes 6,378   (4,616) 
Equity in earnings of joint venture (848)  (3,131) 
Return on investment in joint venture 500     
Operating lease right-of-use asset lease expense 12,959   9,332  
Loss on debt extinguishment 5,685     
Other 148   3,320  
Changes in operating assets and liabilities:        
Accounts receivable, net (139,448)  14,518  
Contract assets (46,182)  (48,115) 
Prepaid expenses and other current assets 1,198   (258) 
Accounts payable 94,542   9,904  
Accrued compensation and benefits 34,355   21,183  
Accrued and other current liabilities (4,110)  (35,799) 
Contract liabilities 120,027   (20,855) 
Operating lease liabilities, current and long-term (10,727)  (7,527) 
Other long-term assets and liabilities (223)  1,338  
         Cash provided by operating activities 162,124   23,229  
         
Cash flows from investing activities:        
Purchases of property and equipment (24,734)  (12,776) 
Consideration paid for acquisitions, net of cash acquired (453)  (220,115) 
Proceeds from sale of property and equipment 226   191  
         Cash used in investing activities (24,961)  (232,700) 
         
Cash flows from financing activities:        
Term loan borrowings (including $2,495 and $38,500 in 2025 and 2024,
respectively, from related parties)
 2,495   250,000  
Term loan payments (including $74,826 in 2025 to related parties) (795,073)  (9,572) 
Notes payable payments (6,102)  (3,990) 
Finance lease payments (2,694)  (1,798) 
Cash distributions to Legence Parent    (1,662) 
Cash contributions from Legence Parent    400  
Proceeds from IPO, net of discounts 780,243     
Debt issuance costs    (1,091) 
Payments of contingent consideration (including ($20,663) in 2024
from related parties)
    (32,429) 
Payments for deferred offering costs (21,165)    
         Cash (used in) provided by financing activities (42,296)  199,858  
Increase (decrease) in cash and cash equivalents 94,867   (9,613) 
Cash and cash equivalents, beginning of period 81,167   88,920  
Cash and cash equivalents, end of period$176,034  $79,307  
  


Non-GAAP Financial Measures
 

In addition to disclosing financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), our earnings release contains non-GAAP financial measures as described below.

In addition, this press release includes certain projections of the non-GAAP financial measure Adjusted EBITDA. Due to the high variability and difficulty in making accurate forecasts and projections of some of the information excluded from these projected measures, together with some of the excluded information not being ascertainable or accessible, the Company is unable to quantify certain amounts that would be required to be included in the most directly comparable GAAP financial measures without unreasonable effort. Consequently, no disclosure of estimated comparable GAAP measures is included and no reconciliation of the forward-looking non-GAAP financial measures is included.

Net Debt

Net debt includes total balance sheet debt, excluding finance lease liabilities, less cash and cash equivalents. The Company believes this non-GAAP measure is useful to investors as it provides a measure to compare debt less cash and cash equivalents across periods on a consistent basis.

Adjusted EBITDA

Adjusted EBITDA is a financial measure not presented in accordance with GAAP but is intended to provide useful and supplemental information to investors and analysts as they evaluate our performance. EBITDA is defined as earnings before interest and other financing expenses, taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA adjusted to exclude goodwill impairment, net loss on sale and disposition of property and equipment, changes in the fair value of contingent consideration liabilities, acquisition and integration costs, system deployment costs, strategic initiative costs, stock-based compensation expense, profits from an accelerated project sale, credit agreement amendment fees and litigation settlements. Adjusted EBITDA should not be considered an alternative to net loss that is derived in accordance with GAAP. Management believes that the exclusion of the above-described items from net loss in the presentation of the non-GAAP measure identified above enables us and our investors to more effectively evaluate our operations period over period and to identify operating trends that might not be apparent due to, among other reasons, the variable nature of these items, both in value and frequency, period over period. In addition, management believes this measure may be useful for investors in comparing our operating results with those of other companies.

Our non-GAAP financial measures may not be comparable to similarly titled measures used by other companies, have limitations as analytical tools and should not be considered in isolation, or substitutes for analysis of our operating results as reported under GAAP. Additionally, we do not consider our non-GAAP financial measures superior to, or a substitute for, the equivalent measures calculated and presented in accordance with GAAP.

The following table provides a reconciliation of our net loss, the most directly comparable financial measure presented in accordance with GAAP, to Adjusted EBITDA for the periods presented herein (in thousands):

  Three Months Ended
September 30,
 Nine Months Ended
September 30,
 
  2025
 2024
 2025
 2024
 
Net income (loss)
$379  $(676) $(22,629) $(9,443) 
 Interest expense 28,183   23,707   88,228   65,392  
 Interest income (1,069)  (523)  (2,588)  (4,356) 
 Income tax expense 4,078   4,564   13,662   9,500  
 Depreciation and amortization 27,490   28,666   85,611   80,987  
 Credit agreement amendment fees(1) 64      2,990   4,119  
 Net loss (gain) on sale and disposition
of property and equipment
 21   (118)  (199)  (299) 
 Loss on debt extinguishment 5,685      5,685     
 Acquisition and integration costs(2) 1,169   881   2,935   7,069  
 System deployment costs(3)    1,393   2,140   3,909  
 Strategic initiative costs(4) 4,181   2,022   14,128   7,233  
 Stock-based compensation expense 18,640   4,040   21,881   8,726  
Adjusted EBITDA
$88,821  $63,956  $211,844  $172,837  
Net income (loss) margin
 0.1 %  (0.1)%  (1.2)%  (0.6)% 
Adjusted EBITDA margin
 12.5 %  11.4 %  11.7 %  11.1 % 
                  
                  
(1)Represents costs incurred in connection with our debt refinancings in each of the periods presented.
(2)For the three months ended September 30, 2025 and 2024, the figures include $0.8 million and $0.2 million, respectively, of acquisition costs recorded in acquisition-related costs and $0.4 million and $0.7 million, respectively, of acquisition integration costs recorded in selling, general and administrative costs in the Consolidated Condensed Statement of Operations. For the nine months ended September 30, 2025 and 2024, the figures include $1.0 million and $5.6 million, respectively, of acquisition costs recorded in acquisition-related costs and $1.9 million and $1.5 million, respectively, of acquisition integration costs recorded in selling, general and administrative costs in the Consolidated Condensed Statement of Operations.
(3)Represents consulting and initial upfront costs associated with implementing and optimizing certain enterprise resource planning systems, including IFS, Onestream and Ceridian Dayforce.
(4)Represents (i) consulting costs associated with rebranding efforts in connection with our name change to Legence that we do not expect to recur in the future, (ii) upfront consulting and out-of-pocket costs related to developing and launching the cross-selling framework amongst our brands, many of which were more recently acquired and integrated into the Legence brand, (iii) consulting and legal fees associated with education and marketing efforts for our clients with respect to utilizing certain government incentive programs and (iv) consulting, legal, accounting, and other expenses in connection with non-recurring extraordinary company transactions, including fees related to our IPO that did not meet the requirements to be deferred issuance costs.
  


Backlog and Awarded Contracts and Book-to-Bill Ratio
 

We also track backlog and awarded contracts and our book-to-bill ratio. We believe that backlog and awarded contracts and book-to-bill ratio enable us to more effectively forecast our future results and working capital needs, as well as better identify future operating trends that may not otherwise be apparent. Backlog represents, as of any date of determination, the expected revenue values of the remaining performance obligations under our contracted fixed-price projects. Awarded contracts represents, as of any date of determination, the expected revenue values of projects awarded to us following a request for proposals but for which a formal contract has not yet been signed. We calculate our book-to-bill ratio by taking our additions to backlog and awarded contracts, excluding additions that were attained through acquisition, for the period, and dividing it by revenue from fixed-price contracts for the same period. Given that backlog and awarded contracts and book-to-bill ratio are operational measures and that our methodology for calculating each such measure does not meet the definition of a non-GAAP financial measure, as that term is defined by the SEC, a quantitative reconciliation for each is not required nor provided.

                                                        

1 Adjusted EBITDA and net debt are non-GAAP financial measures. Definitions of non-GAAP financial measures and reconciliations of each non-GAAP financial measure to the most directly comparable GAAP financial measure are included in the section titled “Non-GAAP Financial Measures.”

2 See “Backlog and Awarded Contracts and Book-to-Bill Ratio” for more information.


FAQ

What were Legence (LGN) Q3 2025 revenue and adjusted EBITDA results?

Legence reported Q3 2025 revenue of $708.0 million and non-GAAP Adjusted EBITDA of $88.8 million.

How large is Legence's backlog and what was the book-to-bill in Q3 2025 for LGN?

Total backlog and awarded contracts were $3.07 billion at Sept 30, 2025, with a consolidated book-to-bill of 1.5x for the quarter.

What is the value and expected timing of Legence's acquisition of Bowers (LGN)?

Legence signed a definitive agreement to acquire Bowers for $475 million, expected to close in Q1 2026 pending customary conditions and regulatory approval.

How did Legence (LGN) use IPO proceeds and what is the company's net debt after the offering?

Legence applied $780.2 million of IPO net proceeds to pay down its term loan, reducing net debt to approximately $650 million and net leverage to 2.4x.

What guidance did Legence (LGN) provide for Q4 2025 and full year 2026?

Q4 2025 guidance: $600M–$630M revenue and $60M–$65M non-GAAP Adjusted EBITDA. Full-year 2026 guidance: $2.65B–$2.85B revenue and $295M–$315M Adjusted EBITDA.

What were the material acquisitions Legence closed in October 2025 and their financial scale?

On Oct 1, 2025, Legence completed acquisitions of AZPE and IMD (combined estimated 2025 revenue ~$25 million); total consideration for those deals was approximately $22 million with ~21% paid in equity.
Legence Corp.

NASDAQ:LGN

LGN Rankings

LGN Latest News

LGN Latest SEC Filings

LGN Stock Data

1.95B
26.00M
Engineering & Construction
Industrials
Link
United States
San Jose